Live tape
Top 8, mentions 7d6,248META1,814 mentions▲ +0.06GOOGL1,262 mentions▲ +0.02NVDA724 mentions▲ +0.09MSFT541 mentions▲ +0.05MUSE508 mentions▲ +0.06TSLA484 mentions▲ +0.05SPY478 mentions▲ +0.04QQQ437 mentions▲ +0.07

Equity · Healthcare

PBH

Prestige Consumer Healthcare Inc. · NYSE

$52.18 +1.44% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Aug 26, 2026
Price · Chart
Our own end-of-day closes 37 sessions
$60 $45 1 Jul 26 Aug

The line runs $48.13 on 1 July through $52.18 on 26 August, on a scale from $45 to $60. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of PBH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 37 sessions over that window: $48.13 on 1 July 2026 through $52.18 on 26 August 2026.

Market cap $2.5B
P/E (TTM) 14.6
52-week range $45 – $70
Avg volume 86.6K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Aug 26, 2026

PBH insider trades

SEC Form 4

PBH has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 December 2025.

Date Insider Type Shares Value
01 Dec 2025 Zerillo Jeffrey Senior VP Operations Sell 281 $17K
28 Nov 2025 Zerillo Jeffrey Senior VP Operations Sell 719 $43K
25 Nov 2025 BYOM JOHN E Sell 3,000 $178K

PBH reported financials

SEC EDGAR XBRL

PBH reported revenue of $1.1B for the fiscal year ended 31 Mar 2026. Net income over the same period was $190.3M.

Figure Reported Period
Revenue $1.1B 31 Mar 2026 fiscal year
Net income $190.3M 31 Mar 2026 fiscal year
Diluted EPS $3.91 31 Mar 2026 fiscal year
Total assets $4.6B 30 Jun 2026 at period end
Total equity $1.9B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

PBH earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q1 2027 $0.61 —
31 Mar 2026 FY 2026 $3.91 —
31 Dec 2025 Q3 2026 $0.97 —
30 Sep 2025 Q2 2026 $0.86 —
30 Jun 2025 Q1 2026 $0.95 —
31 Mar 2025 FY 2025 $4.29 —
31 Dec 2024 Q3 2025 $1.22 —
30 Sep 2024 Q2 2025 $1.09 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

PBH institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a PBH position for the quarter ended 30 Jun 2026 — a combined $69.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Citadel Advisors Added +207.5% shares 564,157 $26.7M
D. E. Shaw & Co. Held (±25%) −17.7% shares 313,778 $14.8M
Fisher Asset Management Held (±25%) −1.5% shares 247,474 $11.7M
Man Group Held (±25%) −12.8% shares 119,056 $5.6M
Maverick Capital New position 50,975 $2.4M
Bridgewater Associates New position 46,407 $2.2M
Millennium Management Trimmed −82.1% shares 46,340 $2.2M
AQR Capital Management Held (±25%) +0.7% shares 37,005 $1.7M
Marshall Wace Trimmed −43.9% shares 31,011 $1.5M
Two Sigma Investments Trimmed −36.8% shares 4,300 $203K

Source: SEC EDGAR 13F filings

PBH fails-to-deliver

SEC CNS data

On 31 Aug 2026, 2,766 shares of PBH failed to deliver (about $145K).

Settlement date Shares failed Notional % of shares out
31 Aug 2026 2,766 $145K 0.006%
26 Aug 2026 2 $103 <0.001%
25 Aug 2026 1,058 $55K 0.002%
18 Aug 2026 55 $3K <0.001%

Source: SEC fails-to-deliver (CNS) data